Projections to MeA and NAc from plCoA are Topographically Organized
(A) Left, whole-hemisphere view at AP = 0.98 mm from bregma. Scale bar, 500 µm. Right, Magnified images of the areas highlighted inside white dashed lines. Scale bar, 200 µm.
(B) Left, whole-hemisphere view at AP = -1.06 mm from bregma. Scale bar, 500 µm. Right, Magnified images of the areas highlighted inside white dashed lines. Scale bar, 200 µm.
(C) Other plCoA projections not found in cross-sections of the brain found in (A) and (B). Scale bar, 200 µm.
(D) Magnitude of anterograde synaptophysin-eYFP fluorescence in primary downstream targets of plCoA projection neurons ordered by total output strength, colored based on each region’s function.
(E) Schematic for topographic retrograde mapping strategy from MeA and NAc into plCoA. Red retrobeads are injected into MeA or NAc and topographical projection bias is examined along the anterior-posterior axis.
(F) Representative images (top) for injection into MeA (left) or NAc (right) and number of neurons labeled along the anterior-posterior axis as distance (mm) from bregma (bottom). Gray lines denote individual replicates, where colored lines indicate mean ± s.e.m.
(G) Proportion of retrobead-labeled neurons projecting to MeA or NAc for each 100 µm segment as a function of distance from bregma. Dashed line indicates overall balance of all retrobead-labeled neurons across entire plCoA.
(H) Proportion of retrobead-labeled neurons from either target within each plCoA zone. MeA-labeled neurons are significantly enriched in aplCoA compared to NAc-labeled neurons, while NAc-labeled neurons are significantly enriched in pplCoA compared to those labeled from MeA.
(I) Representative histological images for the injection sites in aplCoA (left) and pplCoA (right) from a representative animal. Scale bar, 200 µm.
(J) Representative histological images for MeA from the animal in (J). Scale bar, 200 µm.
(K). Representative histological images for NAc from the animal in (J). Scale bar, 200 µm.
(L) Output strength as a proportion of total fluorescence from aplCoA and pplCoA to MeA and NAc.
(M) Representative histological images for the injection site in plCoA from a representative VGluT1::Cre and VGluT2::Cre animal. Scale bar, 200 µm.
(N) Representative histological images from MeA and NAc from a representative animal of either genotype. Scale bar, 200 µm.
(O) Left, output strength as a proportion of total fluorescence from plCoAVGluT2+ and plCoAVGluT1+ neurons to MeA and NAc. Right, comparison of same data, but by target region within genotype.
(P) Same data as (O), but by target region within genotype.
(Q-V) Mapping collateral projections from NAc- and MeA projecting neurons.
(Q) Representative histological images for the injection site in plCoA from a representative animal receiving retrograde virus into MeA or NAc. Scale bar, 200 µm.
(R) Representative histological images of NAc and MeA retro-Cre targeting (red) and outputs (green).
(S) Comparison of absolute integrated fluorescence intensities in MeA and NAc when retroAAV was injected into NAc (top) or MeA (bottom).
(T) Quantification of fluorescence in selected downstream brain regions from plCoA originating from plCoA-NAc neurons proportional to eYFP fluorescence in NAc (top) or MeA (bottom). Abbreviations: NAc, nucleus accumbens; BNST, bed nucleus of stria terminalis; MeA, medial amygdala; Pir, piriform cortex; BLA, basolateral amygdala; Ahi, amygdalo-hippocampal transition area; pmCoA, posteromedial cortical amygdala; Str, striatum; OT, olfactory tubercle; EA, extended amygdala; IPAC, inferior peduncle of the anterior commissure; AA, anterior amygdala; LA, lateral amygdala; HDB, horizontal limb of the diagonal band; VP, ventral pallidum; AIC, anterior insular cortex; mfb, medial forebrain bundle; MO, medial orbitofrontal cortex; LOT, lateral olfactory tract; ACo, anterior cortical amygdala; AOA, anterior olfactory area; DG, dentate gyrus; Rt, reticular nucleus; LPO, lateral preoptic area; VMH, ventromedial hypothalamus; DEn, dorsal endopiriform claustrum; LH, lateral hypothalamus; IL, infralimbic cortex; DP, dorsal peduncular cortex; LS, lateral septum; CxA, cortex-amygdala transition area; sox, supraoptic decussation; StHy, striohypothalamic nucleus; GP, globus pallidus; PLH, perirhinal cortex; ZI, zona incerta.
Across panels, ns, not significant; * p < 0.05; ** p < 0.01; **** p < 0.0001. Additional specific details of statistical tests can be found in Supplemental Table 1.